What Tricida, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bonita David P | Director | Nov 25 | Open-market sale · S | −3,629,226 | $0.22 | −$798K | 0 |
| Orbimed Advisors Llc | Director | Nov 25 | Open-market sale · S | −3,629,226 | $0.22 | −$798K | 0 |
| Alpern Robert J | Director | Nov 23 | Open-market sale · S | −131,879 | $0.21 | −$27.7K | 0 |
| Bonita David P | Director | Nov 23 | Open-market sale · S | −5,617,300 | $0.21 | −$1.18M | 3,629,226 |
| Orbimed Advisors Llc | Director | Nov 23 | Open-market sale · S | −5,617,300 | $0.21 | −$1.18M | 3,629,226 |
| Bonita David P | Director | Nov 22 | Open-market sale · S | −1,034,421 | $0.22 | −$228K | 9,246,526 |
| Orbimed Advisors Llc | Director | Nov 22 | Open-market sale · S | −1,034,421 | $0.22 | −$228K | 9,246,526 |
| Alpern Robert J | Director | Nov 21 | Open-market sale · S | −27,584 | $0.23 | −$6.34K | 131,879 |
| Venrock Healthcare Capital Partners II, L.p. | 10% owner | Oct 26 | Open-market sale · S | −2,367,174 | $0.46 | −$1.09M | 3,751,406 |
| Venrock Healthcare Capital Partners II, L.p. | 10% owner | Oct 25 | Open-market sale · S | −1,970,418 | $0.57 | −$1.12M | 6,118,580 |
| Venrock Healthcare Capital Partners II, L.p. | 10% owner | Oct 24 | Open-market sale · S | −2,113,948 | $0.61 | −$1.29M | 8,088,998 |
| Venrock Healthcare Capital Partners II, L.p. | 10% owner | Oct 19 | Open-market buy · P | +70,100 | $11.25 | +$789K | 10,202,946 |
| Venrock Healthcare Capital Partners II, L.p. | 10% owner | Oct 19 | Open-market buy · P | +241,366 | $10.29 | +$2.48M | 10,132,846 |
| Venrock Healthcare Capital Partners II, L.p. | 10% owner | Oct 18 | Open-market buy · P | +40,400 | $11.98 | +$484K | 9,891,480 |
| Venrock Healthcare Capital Partners II, L.p. | 10% owner | Oct 17 | Open-market buy · P | +170,292 | $11.67 | +$1.99M | 9,851,080 |
| Venrock Healthcare Capital Partners II, L.p. | 10% owner | Oct 13 | Open-market buy · P | +4,674 | $11.98 | +$56K | 9,680,788 |
| Isern Brian M. | 10% owner | Oct 13 | Open-market sale · S | −5,704 | $11.99 | −$68.4K | 1,575,195 |
| Isern Brian M. | 10% owner | Oct 13 | Open-market sale · S | −23,628 | $11.99 | −$283K | 2,223,350 |
| Isern Brian M. | 10% owner | Oct 12 | Open-market sale · S | −41,277 | $12.53 | −$517K | 1,580,899 |
| Isern Brian M. | 10% owner | Oct 12 | Open-market sale · S | −171,006 | $12.53 | −$2.14M | 2,246,978 |
Loading...